Valsartan Recall
Published:7/18/2018


On July 13, 2018, the FDA has issued a recall on certain manufacturers of valsartan (Diovan). 


What products does the recall apply to?

Certain manufacturers of valsartan and valsartan-hydrochlorothiazide (Diovan and Diovan-HCT). 

What manufacturers are affected?
Solco Healthcare, Major Pharmaceuticals, and Teva Pharmaceuticals Industries, Ltd. 

What is the reason for the recall?
An impurity known as NDMA was found in the recalled products. NDMA has been classified as a probable human carcinogen (a substance that can cause cancer). 

What is the FDA doing about this?

The FDA is investigating the levels of NDMA in the recalled products and evaluating the possible effects it has had on patients taking the affected medications. They will provide additional information when it becomes available. 

What does the FDA recommend?
- The FDA recommends that patients continue to take the recalled products until they can be replaced (as valsartan is used to treat serious medical conditions). 
- The FDA recommends that patients contact their pharmacy to see if the affected products were dispensed to them. 
- If taking an affected product, they should follow the recall instructions provided by the manufacturer. 
- If taking an affected product, contact your physician or pharmacist to discuss changing brands or finding an alternative treatment. 

Is my medication affected? What has HMC Rx Care doing about this?
- We have used some of these manufacturers in the period that this recall affects. 
- We did have two different strengths of valsartan from a single manufacturer still in stock at the time of the recall announcement, and we have already removed these products from our shelves. 
- The products we currently have on our shelf are unaffected by the recall; however, as more demand has been created for the unaffected products there may be shortages of these manufacturers. 

Call us at 706-272-6450 if you have any questions!